(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-1.00%) $83.01
(-1.16%) $1.619
(-0.39%) $2 338.10
(-0.51%) $27.40
(0.39%) $925.70
(-0.14%) $0.933
(-0.10%) $11.01
(-0.21%) $0.799
(0.00%) $92.17
0.56% SEK 0.360
Live Chart Being Loaded With Signals
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project...
Stats | |
---|---|
Dzisiejszy wolumen | 615 527 |
Średni wolumen | 139 503 |
Kapitalizacja rynkowa | 80.90M |
EPS | SEK-0.0747 ( 2023-11-03 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.900 |
ATR14 | SEK0.00600 (1.67%) |
Wolumen Korelacja
Spago Nanomedical AB Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Spago Nanomedical AB Korelacja - Waluta/Towar
Spago Nanomedical AB Finanse
Annual | 2023 |
Przychody: | SEK1.20M |
Zysk brutto: | SEK-22.75M (-1 890.86 %) |
EPS: | SEK-0.430 |
FY | 2023 |
Przychody: | SEK1.20M |
Zysk brutto: | SEK-22.75M (-1 890.86 %) |
EPS: | SEK-0.430 |
FY | 2022 |
Przychody: | SEK1.05M |
Zysk brutto: | SEK-15.60M (-1 480.46 %) |
EPS: | SEK-0.590 |
FY | 2021 |
Przychody: | SEK660 000 |
Zysk brutto: | SEK-16.78M (-2 541.82 %) |
EPS: | SEK-1.430 |
Financial Reports:
No articles found.
Spago Nanomedical AB
Spago Nanomedical AB (publ) develops nanomedicines for cancer diagnostics and treatment primarily in Sweden. It is involved in the development of SN132D, a gadolinium-free MRI contrast agent for the treatment of breast and pancreas cancer under the SpagoPix project; and SN201, a radionuclide therapy for treatment of advanced and metastatic cancer under the Tumorad project. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej